We are live on ! Find out more
EPM

Equitec Proprietary Markets Portfolio holdings

AUM $559M
1-Year Est. Return 230.29%
This Fund
S&P 500
This Quarter Est. Return
-8.03%
1 Year Est. Return
+230.29%
3 Year Est. Return
+526.89%
5 Year Est. Return
+679.16%
10 Year Est. Return
–
AUM
$315M
AUM Growth
-$64.1M
Cap. Flow
-$15.6M
Cap. Flow %
-4.94%
Top 10 Hldgs %
65.01%
Holding
323
New
39
Increased
32
Reduced
45
Closed
116

Top Buys

Rank Stock Value
1
FRG
Franchise Group, Inc.
FRG
+$7.26M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$6.95M
3
TSLA icon
Tesla
TSLA
+$6.51M
4
DNA icon
Ginkgo Bioworks
DNA
+$4.13M
5
AMZN icon
Amazon
AMZN
+$3.09M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$14.3M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$12.3M
3
OEC icon
Orion
OEC
+$6.01M
4
CTXS
Citrix Systems Inc
CTXS
+$5.64M
5
ROG icon
Rogers Corp
ROG
+$5.42M

Sector Composition

Rank Sector Weight
1 Financials 15.66%
2 Industrials 13.47%
3 Technology 4.87%
4 Healthcare 2.89%
5 Consumer Discretionary 2.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ECOM
276
PUT
DELISTED
CHANNELADVISOR CORPORATION
ECOM
– –
-6,600
Closed -$150K
ESSC
277
CALL
DELISTED
East Stone Acquisition Corporation Ordinary Shares
ESSC
– –
-16,400
Closed -$170K
ESSC
278
DELISTED
East Stone Acquisition Corporation Ordinary Shares
ESSC
– –
-16,400
Closed -$170K
ESSC
279
PUT
DELISTED
East Stone Acquisition Corporation Ordinary Shares
ESSC
– –
-11,500
Closed -$119K
CRHC.WS
280
DELISTED
Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CRHC.WS
– –
-1,900
Closed –
FSNB.WS
281
DELISTED
Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
FSNB.WS
– –
-5,000
Closed –
QNGY.WS
282
DELISTED
Quanergy Systems, Inc. Warrants, each whole warrant exercisable for one twentieth (1/20) share of Common Stock at an exercise price of $230.00 per full share
QNGY.WS
– –
-20,000
Closed -$1K
TLGA.WS
283
DELISTED
TLG Acquisition One Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
TLGA.WS
– –
-7,000
Closed –
PRBM.WS
284
DELISTED
Parabellum Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
PRBM.WS
– –
-188,349
Closed -$7K
BENEW
285
DELISTED
Benessere Capital Acquisition Corp. Warrant
BENEW
– –
-50,000
Closed -$9K
TWTR
286
CALL
DELISTED
Twitter, Inc.
TWTR
– –
-3,800
Closed -$167K
TWTR
287
DELISTED
Twitter, Inc.
TWTR
– –
-1,900
Closed -$83K
TWTR
288
PUT
DELISTED
Twitter, Inc.
TWTR
– –
-4,500
Closed -$197K
CCXI
289
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-100
Closed -$5K
CCXI
290
PUT
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-600
Closed -$31K
SHLX
291
DELISTED
Shell Midstream Partners, L.P.
SHLX
– –
-5,700
Closed -$90K
SHLX
292
PUT
DELISTED
Shell Midstream Partners, L.P.
SHLX
– –
-17,800
Closed -$281K
Y
293
DELISTED
Alleghany Corp
Y
– –
-368
Closed -$309K
Y
294
PUT
DELISTED
Alleghany Corp
Y
– –
-2,700
Closed -$2.27M
GETY.WS
295
DELISTED
Getty Images Holdings, Inc. Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
GETY.WS
– –
-20,200
Closed -$1K
PIPP.WS
296
DELISTED
Pine Island Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
PIPP.WS
– –
-10,000
Closed -$1K
FMTX
297
CALL
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
– –
-9,100
Closed -$182K
FMTX
298
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
– –
-6,700
Closed -$134K
FMTX
299
PUT
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
– –
-5,900
Closed -$118K
GBT
300
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-57,700
Closed -$3.93M
9 10 11
12
13

Similar funds

DIM
Delta Investment Management San Francisco, California $559M AUM 19.86% 1-Year Est. Return
CFP
Curran Financial Partners Daniel Island, South Carolina $559M AUM 13.69% 1-Year Est. Return
NCA
Newbrook Capital Advisors New York $560M AUM 62.9% 1-Year Est. Return
OPWM
Oakwell Private Wealth Management Austin, Texas $560M AUM 20.18% 1-Year Est. Return
SHIM
Stone House Investment Management Tunkhannock, Pennsylvania $558M AUM 14.72% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.92% 1-Year Est. Return
CAM
Cander Asset Management New York $557M AUM

Equitec Proprietary Markets's Q4 2022 Portfolio in Review

As of Q4 2022, Equitec Proprietary Markets held 323 positions worth $315M, down 17% from $380M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Equitec Proprietary Markets withdrew a net $15.6M in Q4 2022, closing 116 positions and reducing 45 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $14.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.

Against the trend, Equitec Proprietary Markets opened a new position in iShares Core S&P 500 ETF worth $6.92M.

  • Equitec Proprietary Markets's largest Q4 2022 buy was iShares Core S&P 500 ETF: 18,000 shares worth $6.92M.
  • Equitec Proprietary Markets added most to Franchise Group, Inc. in Q4 2022, an estimated $7.26M increase.
  • Equitec Proprietary Markets's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $12.3M.
  • Equitec Proprietary Markets fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $14.3M.
  • Equitec Proprietary Markets's ten largest holdings make up 65% of its $315M portfolio in Q4 2022.
  • Equitec Proprietary Markets opened 39 new positions and closed 116 in Q4 2022.
  • Equitec Proprietary Markets's portfolio value fell 17% quarter-over-quarter to $315M.

Based on Equitec Proprietary Markets's 13F filing for Q4 2022, filed 31 Jan 2023.